934 related articles for article (PubMed ID: 19018092)
1. Specificity and affinity of human Fcgamma receptors and their polymorphic variants for human IgG subclasses.
Bruhns P; Iannascoli B; England P; Mancardi DA; Fernandez N; Jorieux S; Daëron M
Blood; 2009 Apr; 113(16):3716-25. PubMed ID: 19018092
[TBL] [Abstract][Full Text] [Related]
2. Identification of IgG(1) variants with increased affinity to FcγRIIIa and unaltered affinity to FcγRI and FcRn: comparison of soluble receptor-based and cell-based binding assays.
Lu Y; Vernes JM; Chiang N; Ou Q; Ding J; Adams C; Hong K; Truong BT; Ng D; Shen A; Nakamura G; Gong Q; Presta LG; Beresini M; Kelley B; Lowman H; Wong WL; Meng YG
J Immunol Methods; 2011 Feb; 365(1-2):132-41. PubMed ID: 21185301
[TBL] [Abstract][Full Text] [Related]
3. An Engineered Human Fc variant With Exquisite Selectivity for FcγRIIIa
Kang TH; Lee CH; Delidakis G; Jung J; Richard-Le Goff O; Lee J; Kim JE; Charab W; Bruhns P; Georgiou G
Front Immunol; 2019; 10():562. PubMed ID: 30984171
[TBL] [Abstract][Full Text] [Related]
4. How to select IgG subclasses in developing anti-tumor therapeutic antibodies.
Yu J; Song Y; Tian W
J Hematol Oncol; 2020 May; 13(1):45. PubMed ID: 32370812
[TBL] [Abstract][Full Text] [Related]
5. No association between neutrophil FcgammaRIIa allelic polymorphism and anti-neutrophil cytoplasmic antibody (ANCA)-positive systemic vasculitis.
Tse WY; Abadeh S; McTiernan A; Jefferis R; Savage CO; Adu D
Clin Exp Immunol; 1999 Jul; 117(1):198-205. PubMed ID: 10403936
[TBL] [Abstract][Full Text] [Related]
6. Importance of the Side Chain at Position 296 of Antibody Fc in Interactions with FcγRIIIa and Other Fcγ Receptors.
Isoda Y; Yagi H; Satoh T; Shibata-Koyama M; Masuda K; Satoh M; Kato K; Iida S
PLoS One; 2015; 10(10):e0140120. PubMed ID: 26444434
[TBL] [Abstract][Full Text] [Related]
7. Multi-Angle Effector Function Analysis of Human Monoclonal IgG Glycovariants.
Dashivets T; Thomann M; Rueger P; Knaupp A; Buchner J; Schlothauer T
PLoS One; 2015; 10(12):e0143520. PubMed ID: 26657484
[TBL] [Abstract][Full Text] [Related]
8. Cross-reactivity of mouse IgG subclasses to human Fc gamma receptors: Antibody deglycosylation only eliminates IgG2b binding.
Temming AR; Bentlage AEH; de Taeye SW; Bosman GP; Lissenberg-Thunnissen SN; Derksen NIL; Brasser G; Mok JY; van Esch WJE; Howie HL; Zimring JC; Vidarsson G
Mol Immunol; 2020 Nov; 127():79-86. PubMed ID: 32947169
[TBL] [Abstract][Full Text] [Related]
9. Anti-CD20 rituximab IgG1, IgG3, and IgG4 but not IgG2 subclass trigger Ca
Freitas Monteiro M; Papaserafeim M; Réal A; Puga Yung GL; Seebach JD
J Leukoc Biol; 2020 Oct; 108(4):1409-1423. PubMed ID: 32620047
[TBL] [Abstract][Full Text] [Related]
10. Analysis of Fcgamma receptor IIa (cd32) gene polymorphism and anti-malarial IgG subclass antibodies to asexual blood-stage antigen of Plasmodium falciparum in an unstable malaria endemic area of Iran.
Zakeri S; Mashhadi R; Mehrizi AA; Djadid ND
Exp Parasitol; 2013 May; 134(1):115-21. PubMed ID: 23458236
[TBL] [Abstract][Full Text] [Related]
11. The influence of the hinge region length in binding of human IgG to human Fcgamma receptors.
Redpath S; Michaelsen TE; Sandlie I; Clark MR
Hum Immunol; 1998 Nov; 59(11):720-7. PubMed ID: 9796740
[TBL] [Abstract][Full Text] [Related]
12. Human Fcγ receptors compete for TGN1412 binding that determines the antibody's effector function.
Dudek S; Weißmüller S; Anzaghe M; Miller L; Sterr S; Hoffmann K; Hengel H; Waibler Z
Eur J Immunol; 2019 Jul; 49(7):1117-1126. PubMed ID: 31002172
[TBL] [Abstract][Full Text] [Related]
13. Anti-neutrophil cytoplasm antibody IgG subclasses in Wegener's granulomatosis: a possible pathogenic role for the IgG4 subclass.
Holland M; Hewins P; Goodall M; Adu D; Jefferis R; Savage CO
Clin Exp Immunol; 2004 Oct; 138(1):183-92. PubMed ID: 15373923
[TBL] [Abstract][Full Text] [Related]
14. IgG subclass-independent improvement of antibody-dependent cellular cytotoxicity by fucose removal from Asn297-linked oligosaccharides.
Niwa R; Natsume A; Uehara A; Wakitani M; Iida S; Uchida K; Satoh M; Shitara K
J Immunol Methods; 2005 Nov; 306(1-2):151-60. PubMed ID: 16219319
[TBL] [Abstract][Full Text] [Related]
15. Nonfucosylated therapeutic IgG1 antibody can evade the inhibitory effect of serum immunoglobulin G on antibody-dependent cellular cytotoxicity through its high binding to FcgammaRIIIa.
Iida S; Misaka H; Inoue M; Shibata M; Nakano R; Yamane-Ohnuki N; Wakitani M; Yano K; Shitara K; Satoh M
Clin Cancer Res; 2006 May; 12(9):2879-87. PubMed ID: 16675584
[TBL] [Abstract][Full Text] [Related]
16. Expression of human FcgammaRIIIa as a GPI-linked molecule on CHO cells to enable measurement of human IgG binding.
Armour KL; Smith CS; Clark MR
J Immunol Methods; 2010 Mar; 354(1-2):20-33. PubMed ID: 20138184
[TBL] [Abstract][Full Text] [Related]
17. Anticardiolipin IgG subclasses: association of IgG2 with arterial and/or venous thrombosis.
Sammaritano LR; Ng S; Sobel R; Lo SK; Simantov R; Furie R; Kaell A; Silverstein R; Salmon JE
Arthritis Rheum; 1997 Nov; 40(11):1998-2006. PubMed ID: 9365089
[TBL] [Abstract][Full Text] [Related]
18. Enhanced Effector Functions Due to Antibody Defucosylation Depend on the Effector Cell Fcγ Receptor Profile.
Bruggeman CW; Dekkers G; Bentlage AEH; Treffers LW; Nagelkerke SQ; Lissenberg-Thunnissen S; Koeleman CAM; Wuhrer M; van den Berg TK; Rispens T; Vidarsson G; Kuijpers TW
J Immunol; 2017 Jul; 199(1):204-211. PubMed ID: 28566370
[TBL] [Abstract][Full Text] [Related]
19. Characterization and refinement of monoclonal anti-human globulins that lack reactivity with human IgG4.
Howie HL; Collins B; Wang X; Kapp L; Delaney M; Er LS; Lebedev JN; Zimring JC
Transfusion; 2020 May; 60(5):1060-1068. PubMed ID: 32369193
[TBL] [Abstract][Full Text] [Related]
20. Highly sensitive HPLC analysis and biophysical characterization of N-glycans of IgG-Fc domain in comparison between CHO and 293 cells using FcγRIIIa ligand.
Kosuge H; Nagatoishi S; Kiyoshi M; Ishii-Watabe A; Tanaka T; Terao Y; Oe S; Ide T; Tsumoto K
Biotechnol Prog; 2020 Nov; 36(6):e3016. PubMed ID: 32390308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
